We integrate spatial omics with pharmaceutics to determine the factors that influence treatment response, and develop data-driven precision therapies

Key Words: Tissue signature; Cancer immunotherapy; Lymphoid tissues; Biomarker;

We harness the rich information carried by extracellular vesicles to monitor blood-borne tissue and disease-specific signatures, and develop biomimetic drug delivery technologies.

Key Words: Diagnostics; Biomimetic drug delivery

We develop microfluidic devices to monitor the health and therapeutic response of patients, and learn how to transition back to a healthy state.

Key Words: Microfluidics; Biosensor; PK/PD